14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for PIRS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 11.56 4.33 %
R2 11.33 2.26 %
R1 11.19 0.99 %
Current price: 11.08
Support S1 10.73 -3.15 %
S2 10.59 -4.43 %
S3 10.36 -6.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 12.00 8.30 %
R2 11.68 5.42 %
R1 11.24 1.44 %
Current price 11.08
Support S1 0 .
S2 0 .
S3 0 .

PIRS Predictions History

3 years ago
JS predicted that PIRS for 2021-03-08 is going $2.60 (7.88%)

3 years ago
SHAMOO predicted that PIRS for 2021-03-08 is going

3 years ago
Billy Bob predicted that PIRS for 2021-03-08 is going $3.00 (16.73%)

Rank:

3 years ago
JS predicted that PIRS for 2021-03-04 is going $2.68 (7.20%)

3 years ago
Tonie Garcia predicted that PIRS for 2021-03-04 is going

Rank:

3 years ago
Billy Bob predicted that PIRS for 2021-03-04 is going $2.69 (-0.37%)

Rank:

3 years ago
sander7100 yo bro predicted that PIRS for 2021-03-03 is going $2.72 (0.74%)

3 years ago
JS predicted that PIRS for 2021-03-03 is going $2.70 (0.00%)

3 years ago
Phillip DiFatta predicted that PIRS for 2021-03-03 is going

Rank:

3 years ago
jfenst310.219790 predicted that PIRS for 2021-03-03 is going

Rank:
Click to get the best stock tips daily for free!

About Pieris Pharmaceuticals

Pieris Pharmaceuticals Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate ... PIRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT